Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.
Deirdre
D
Cronin-Fenton
Timothy L
TL
Lash
Henrik T
HT
Sørensen
D000483:Alleles; D018931:Antineoplastic Agents, Hormonal / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001711:Biotransformation / Q000187:drug effects; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D015283:Citalopram / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D003718:Denmark / Q000453:epidemiology; D003863:Depression / Q000150:complications / Q000188:drug therapy; D004347:Drug Interactions; D004967:Estrogens; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D015283:Citalopram; D019389:Cytochrome P-450 CYP2D6; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D004967:Estrogens; D017367:Selective Serotonin Reuptake Inhibitors; D013629:Tamoxifen; C055492:4-hydroxy-N-desmethyltamoxifen